Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Lymphoma 22Breast Neoplasms 16Leukemia 13Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Hodgkin Disease 11Neuroblastoma 10Lymphoma, Follicular 10Burkitt Lymphoma 10Leukemia, Myeloid, Acute 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neutropenia 8Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Acute 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Neoplasms, Plasma Cell 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Malignant mesenchymal tumor 5Congenital Abnormalities 5Rhabdomyosarcoma 4Leukemia, Myeloid, Chronic-Phase 4Kidney Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4Endometrial Neoplasms 4Central Nervous System Neoplasms 4Carcinoma, Non-Small-Cell Lung 4

Interventions

pegfilgrastim 2pegylated granulocyte colony-stimulating factor 1Vancomycin 1TKN732 1Linezolid 1Levofloxacin 1Filgrastim 1Bevacizumab 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Febrile Neutropenia × Filgrastim × Clear all
NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Biocad

Phase 3 Completed
135 enrolled 18 charts
BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡